Secretory Leucoprotease Inhibitor Impairs Toll-Like Receptor 2- and 4-Mediated Responses in Monocytic Cells

Secretory leucoprotease inhibitor (SLPI) is an anti-inflammatory antiprotease which can inhibit lipopolysaccharide-induced NF-κB activation. We examined its ability to inhibit NF-κB activation induced by lipoteichoic acid and investigated the effects of oxidation or complex formation with neutrophil...

Full description

Saved in:
Bibliographic Details
Main Authors: Greene, Catherine M., McElvaney, Noel G., O'Neill, Shane J., Taggart, Clifford C.
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2004
Subjects:
Host Response and Inflammation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC415654/
https://ncbi.nlm.nih.gov/pubmed/15155685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.72.6.3684-3687.2004
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items